Anti-CPV Capsid Antibody (Mab14)
The Anti-CPV Capsid Antibody (Mab14) is a highly specific monoclonal antibody that targets the capsid protein of Canine Parvovirus (CPV). This powerful antibody is designed to provide reliable and accurate results in various applications, making it an essential tool for biotech researchers and veterinarians.
Biological Function
The main function of the Anti-CPV Capsid Antibody (Mab14) is to bind to the capsid protein of CPV, preventing the virus from infecting host cells. This antibody is produced by hybridoma technology, ensuring high specificity and purity. It has been extensively validated for its ability to detect CPV in various samples, making it a trusted tool for CPV research.
Main Applications
The Anti-CPV Capsid Antibody (Mab14) is primarily used for the detection and quantification of CPV in biological samples. It can be used in various immunoassays such as ELISA, Western blot, and immunohistochemistry. This antibody is also suitable for in vitro and in vivo studies to understand the pathogenesis of CPV and evaluate potential antiviral therapies.
Experimental Use Cases
The Anti-CPV Capsid Antibody (Mab14) has been successfully used in various research studies to advance our understanding of CPV and develop effective treatments. In one study, this antibody was used to identify a new CPV strain and determine its virulence. In another study, it was used to evaluate the efficacy of a novel antiviral drug against CPV. These examples demonstrate the versatility and reliability of the Anti-CPV Capsid Antibody (Mab14) in CPV research.
With its high specificity and sensitivity, the Anti-CPV Capsid Antibody (Mab14) is a valuable tool for biotech researchers and veterinarians working on CPV. Its applications in various immunoassays and experimental studies make it an essential component of any CPV research project. Order now and unlock the full potential of this powerful antibody for your research needs.
Keywords: Anti-CPV Capsid Antibody, Mab14, Canine Parvovirus, monoclonal antibody, immunoassays, ELISA, Western blot, immunohistochemistry, pathogenesis, antiviral therapies, virulence, sensitivity, specificity, hybridoma technology, biotech researchers, veterinarians, research studies, experimental use cases.
There are no reviews yet.